For years, AbbVie's (NYSE: ABBV) powerhouse product Humira has held the top-dog position of best-selling drug in the world. In 2016, this anti-inflammatory drug brought in over $16 billion in global sales and is expected to remain the world's top-selling drug out to 2020. However, being lead husky means the competition is always nipping at your heels, and competitors are itching to knock Humira off its perch.
Abbvie's Eagerly Anticipated Followup To Humira Is Coming: What You Need To Know
newsfeedback@fool.com (David Liang), The Motley Fool
Fri, 06/23/2017 - 5:06am
BING NEWS:
- STAT+: Thanks to CVS, a biosimilar version of AbbVie's Humira is grabbing huge market share
The number of new prescriptions written for biosimilar versions of the Humira rheumatoid arthritis treatment, one of the best-selling medicines in the U.S., surged to 36% from just 5% during the ...
04/15/2024 - 5:57 am | View Link - AbbVie’s Humira outperforms forcing biosimilar maker to cut sales staff
Boehringer Ingelheim has decided to reduce its U.S. salesforce as its biosimilars targeting AbbVie's (NYSE:ABBV) blockbuster arthritis therapy, Humira, has lagged expectations, the German ...
04/5/2024 - 2:30 am | View Link - AbbVie’s Humira outperforms forcing biosimilar maker to cut sales staff
AbbVie has retained 98% of the Humira market, even as in 2023 alone, the U.S. witnessed the market entry of nine biosimilars targeting the therapy, once the world's bestselling drug.According to ...
04/5/2024 - 1:35 am | View Link - Celltrion launches biosimilar of AbbVie's blockbuster drug Humira in US
(Reuters) - South Korea's Celltrion Healthcare has launched a copycat version to AbbVie Inc's Humira at about a 5% discount, adding to the growing competition for the blockbuster rheumatoid ...
07/5/2023 - 1:15 am | View Link - Dutch Judges To Decide Whether Humira’s Price And AbbVie’s Profits Are “Too High”
Opinions expressed by Forbes Contributors are their own. I write about healthcare policy, with an emphasis on Rx drugs. In a unique challenge to drug makers, the Dutch Pharmaceutical ...
03/1/2023 - 1:07 am | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more